Latest Update: MedPlus IPO listed at 31% premium on Indices. Medplus share price listed at ₹1040 on NSE & ₹1015 on BSE respectively. The stock is listed as per the IPO Watch team predicted. Happy Investing!
MedPlus Share Price Live Quote
| Details | BSE Listing | NSE Listing |
| IPO Price |
₹796.00
|
₹796.00
|
| List Price |
₹1015.00
|
₹1040.00
|
| High Price |
₹1143.10
|
₹1143.90
|
| Low Price |
₹1015.00
|
₹1040.00
|
| Close Price |
₹1120.85
|
₹1121.15
|
| Volume |
1,199,056
|
18,407,607
|
BSE Notice of Listing: Notice
MedPlus IPO Listing Details
| BSE Code | 543427 |
| NSE Code | MEDPLUS |
| Group | B Group |
| ISIN No | INE804L01022 |
| Offer Price | ₹796 |
| Face Value | ₹2 |
| Listing Date | 23 December 2021, Thursday |
Important Links:
MedPlus IPO Subscription Status (Final Data)
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 0.06 | 0.09 | 111.90 |
| NII | 0.16 | 0.50 | 85.33 |
| RII | 1.29 | 2.64 | 5.24 |
| EMP | 0.76 | 1.73 | 3.05 |
| Total | 0.70 | 1.46 | 52.59 |
MedPlus IPO Date & Price Band
| IPO Open: | 13 December 2021 |
| IPO Close: | 15 December 2021 |
| IPO Size: | Approx ₹1398 Crores |
| Fresh Issue: | Approx ₹600 Crores |
| Offer for Sale: | Approx ₹798 Crores |
| Face Value: | ₹2 Per Equity Share |
| Price Band: | ₹780 to ₹796 Per Share |
| Listing on: | BSE & NSE |
| Retail Quota: | 35% |
| QIB Quota: | 50% |
| NII Quota: | 15% |
| Discount: | ₹78 for Employees |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
MedPlus IPO Market Lot
| Minimum Lot Size: | Minimum 18 Shares for 1 lot |
| Minimum Amount: | ₹14,328 for 1 lot |
| Maximum Lot Size: | Maximum 234 Shares for 13 lot |
| Maximum Amount: | ₹186,264 for 13 lot |
MedPlus IPO Time Table
| Price Band Announcement: | 07 December 2021 |
| Anchor Investors Allotment: | 12 December 2021 |
| IPO Open Date: | 13 December 2021 |
| IPO Close Date: | 15 December 2021 |
| Basis of Allotment: | 20 December 2021 |
| Refunds: | 21 December 2021 |
| Credit to Demat Account: | 22 December 2021 |
| IPO Listing Date: | 23 December 2021 |
MedPlus IPO Listing FAQs:
Follow IPO Watch for the latest IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
